W.H.O. issues strong recommendation for critically ill patients. Dexamethasone appears to reduce deaths by 36%; hydrocortisone by 31%.
“Based on the new evidence, the World Health Organization issued new treatment guidance, strongly recommending steroids to treat severely and critically ill patients, but not to those with mild disease,” writes Caryn Rabin in The New York Times.
“Clearly, now steroids are the standard of care,” said Dr. Howard C. Bauchner, the editor-in-chief of JAMA, which published five papers about the treatment.”
“Steroids like dexamethasone, hydrocortisone and methylprednisolone are often used by doctors to tamp down the body’s immune system, alleviating inflammation, swelling and pain. Many COVID-19 patients die not of the virus but of the body’s overreaction to the infection.”
Steroids linked to a one-third reduction in deaths among COVID-19 patients
“Dexamethasone produced the strongest results: a 36% drop in deaths in 1,282 patients treated in three separate trials.”
“Hydrocortisone, tested in 374 patients in three trials, appeared to reduce deaths by 31%…”
See entire article: